EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Metabolism-driven Immune Escape Defines Therapeutic Vulnerability in Type I and Type II Ovarian Cancer

Kohei Miyata, Fusanori Yotsumoto

Anticancer Research · 2026

DOI: 10.21873/anticanres.18164 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Anticancer Research, 2026. Verfasst von Kohei Miyata und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Tumor Escape. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsTumor EscapeHumansFemaleMetabolic ReprogrammingTumor MicroenvironmentImmunotherapyAnimalsImmune Checkpoint InhibitorsSignal Transduction

Stichwörter der Autor:innen

Ovarian cancercancer metabolismimmune checkpoint inhibitorprecision immunotherapyreviewtumor immunology

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
  • Department of Obstetrics and Gynecology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan yotsumoto@fukuoka-u.ac.jp.

Zitieren

APA

Miyata, K., & Yotsumoto, F. (2026). Metabolism-driven Immune Escape Defines Therapeutic Vulnerability in Type I and Type II Ovarian Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.18164

Vancouver

Miyata K, Yotsumoto F. Metabolism-driven Immune Escape Defines Therapeutic Vulnerability in Type I and Type II Ovarian Cancer. Anticancer Research. 2026. doi:10.21873/anticanres.18164

BibTeX
@article{Miyata2026,
  author = {Miyata, Kohei and Yotsumoto, Fusanori},
  title = {Metabolism-driven Immune Escape Defines Therapeutic Vulnerability in Type I and Type II Ovarian Cancer},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.18164}
}
Kostenlos starten →